Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karine Lacombe

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
La Revue Du Praticien|July 28, 2022
[Infection par le SARS-CoV-2 : deux ans et demi de lutte contre la pandémie]Karine Lacombe
Clinics and Research in Hepatology and Gastroenterology|April 7, 2012
Primary liver cancer among cirrhosis patients with and without HIV infectionKarine Lacombe
La Revue Du Praticien|July 28, 2022
[Infection par le SARS-CoV-2 : 10 messages clés]Karine Lacombe
Journal of the International AIDS Society|November 14, 2014
Hepatitis C, from screening to treatment, a revolutionKarine Lacombe
AIDS (London, England)|June 30, 2018
Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?Karine Lacombe
La Revue Du Praticien|June 17, 2006
[HIV infection and comorbidities]Karine Lacombe, Jérôme Pacanowski
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen: toward elimination of nucleic acid testing?Maud Lemoine, Karine Lacombe
Clinics and Research in Hepatology and Gastroenterology|March 26, 2013
Hepatoxicity of new antiretrovirals: a systematic reviewLaure Surgers, Karine Lacombe
Gut|April 17, 2012
HIV and viral hepatitis coinfections: advances and challengesKarine Lacombe, Juergen Rockstroh
The Journal of Infectious Diseases|September 4, 2015
Breaking Down Barriers to Care in Hepatitis C Virus InfectionMark Thursz, Karine Lacombe
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
La Revue Du Praticien|July 28, 2022
[Infection par le SARS-CoV-2 : deux ans et demi de lutte contre la pandémie]Karine Lacombe
Clinics and Research in Hepatology and Gastroenterology|April 7, 2012
Primary liver cancer among cirrhosis patients with and without HIV infectionKarine Lacombe
La Revue Du Praticien|July 28, 2022
[Infection par le SARS-CoV-2 : 10 messages clés]Karine Lacombe
Journal of the International AIDS Society|November 14, 2014
Hepatitis C, from screening to treatment, a revolutionKarine Lacombe
AIDS (London, England)|June 30, 2018
Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?Karine Lacombe
La Revue Du Praticien|June 17, 2006
[HIV infection and comorbidities]Karine Lacombe, Jérôme Pacanowski
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen: toward elimination of nucleic acid testing?Maud Lemoine, Karine Lacombe
Clinics and Research in Hepatology and Gastroenterology|March 26, 2013
Hepatoxicity of new antiretrovirals: a systematic reviewLaure Surgers, Karine Lacombe
Gut|April 17, 2012
HIV and viral hepatitis coinfections: advances and challengesKarine Lacombe, Juergen Rockstroh
The Journal of Infectious Diseases|September 4, 2015
Breaking Down Barriers to Care in Hepatitis C Virus InfectionMark Thursz, Karine Lacombe
Pageof 28